Concepedia

Sepehr Farahbakhshian

SF

Statistics

Publications

6

Citations

186

H-Index

6

Active since

1998

Affiliations

Takeda (United States)(Current)

Sepehr Farahbakhshian is an author at Takeda (United States) specializing in economic burden of disease, medicine, and cost-effectiveness analysis.

Publications per year

1998–2022

6

Publications

6

Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes

Yong-Jiang Hei, Sepehr Farahbakhshian, Xunsheng Chen et al. · Molecular and Cellular Biochemistry · 1998 · 71 citations

Life Sciences, Biochemistry, Physiology +13

Economic burden of comorbid chronic kidney disease and diabetes

Robert B. McQueen, Sepehr Farahbakhshian, Kelly Bell et al. · Journal of Medical Economics · 2017 · 50 citations

Pharmacy, Nephrology, Pharmacoeconomics +17

Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder

Lenard A. Adler, Sepehr Farahbakhshian, Beverly Romero et al. · Postgraduate Medicine · 2019 · 31 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +13

Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses

David Coghill, Tamara Werner‐Kiechle, Sepehr Farahbakhshian et al. · European Child & Adolescent Psychiatry · 2020 · 12 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +14

Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States

Mei Lü, Abiola Oladapo, Yanyu Wu et al. · Journal of Managed Care & Specialty Pharmacy · 2020 · 12 citations · Full text

Medicine, Hematology, Pharmacoeconomics +17

1–5 of 6